News Sentiment

BRKR sentiment intelligence

Bruker Corporation news scored across direct company coverage, industry context, sector read-through, source quality, and freshness.

Chart Weekly report Factors RSS feed
Weighted score 57 Balanced news tone 68 relevant articles
Exchange NASDAQ United States
Sector Healthcare Market context
Industry Medical Devices Read-through group
Latest close 60.06 Week of 10 Jul 2026
Weighted tone 57/100

Balanced news tone

Market reaction Balanced read

News tone and price action are not far from neutral.

Primary event Market update

75/100 classification confidence.

Company focus 57

directly relevant articles

Source quality 1

high-authority source matches

Trend context Trend active

-2.6% over one week, +10.8% over four weeks, trend active, and near fair-value range.

Latest direct headline Neutral

Goldman Sachs Maintains Bruker Corp(BRKR.US) With Sell Rating, Raises Target Price to $40

Market Reaction

Balanced read

65/100 confidence

News tone and price action are not far from neutral.

Primary event Market update 75/100 classification
One-week reaction -2.6% Price reacting lower
Trend fit Trend active 10.8% over four weeks
Fair value 9.1% Near fair-value range

Sentiment Mix

Positive, neutral, negative

Weighted by relevance
Positive 23
Neutral 44
Negative 1

Relevance

Why the article matched

Direct first
Direct company coverage 57
Industry context 11
Sector context 0

Sources

Coverage mix

Publishers
Market source 15
Moomoo 6
Stock Titan 6
simplywall.st 4
TradingKey 4
GuruFocus 3
MT Newswires 2
Business Wire 2

Event Lens

What the news is about

Classified themes
Market update 28
Earnings 21
Analyst action 11
Balance sheet 3
Deals and strategy 2
Macro sensitivity 2
Guidance 1

Sentiment Trail

Score over time

50 baseline
Above 50 Neutral zone Below 50

News Tape

Relevant headlines

Showing 1-30 of 68
Stock Titan Direct company coverage

BRKR (NASDAQ: BRKR) holder plans July 2026 sale of 2,000 shares

Mark R. Munch, a holder of Bruker Corporation (NASDAQ: BRKR) shares, has filed a Form 144 notice to sell 2,000 common shares on or after July 15, 2026, through Morgan Stanley Smith Barney LLC. The proposed sale, which will be executed on NASDAQ, has an estimated total value of $1

Tone
Neutral 50/100
Event
Market update
Published
15 Jul 2026 20:40
Source
Stock Titan
Investing.com Direct company coverage

Bruker acquires clinical metagenomics platform from Noscendo

Bruker Corporation has acquired the DISQVER clinical metagenomics platform from Noscendo GmbH, enhancing its next-generation sequencing-based infection detection capabilities. The platform, which analyzes microbes directly from blood samples and searches for over 11,000 different

Tone
Positive 70/100
Event
Market update
Published
15 Jul 2026 11:14
Source
Investing.com
Stock Titan Direct company coverage

Bruker's Research-Only Platform Analyzes Blood in Under 24 Hours

Bruker (NASDAQ: BRKR) has acquired the DISQVER® platform, expanding its infection detection portfolio with metagenomic next-generation sequencing (mNGS) capabilities for pathogenic microorganisms in blood. This platform allows for rapid and comprehensive whole genome sequencing a

Tone
Positive 70/100
Event
Market update
Published
15 Jul 2026 11:14
Source
Stock Titan
Investing.com Direct company coverage

Guggenheim reiterates Bruker stock Buy rating on metrology demand

Guggenheim reiterated a Buy rating and a $70.00 price target for Bruker (NASDAQ:BRKR) after researching the company's semiconductor growth prospects, particularly in its metrology segment. The firm projects approximately 30% growth for Bruker's metrology segment next year, contin

Tone
Positive 73/100
Event
Analyst action
Published
13 Jul 2026 12:42
Source
Investing.com
MarketBeat Direct company coverage

Bruker Corporation $BRKR Shares Bought by Candriam S.C.A.

Candriam S.C.A. significantly increased its stake in Bruker Corporation (NASDAQ:BRKR) by 23.5% in the first quarter, now owning 676,424 shares valued at $24.4 million. This comes after Bruker reported better-than-expected quarterly results, with EPS of $0.31 and revenue of $823.4

Tone
Neutral 50/100
Event
Earnings
Published
12 Jul 2026 15:39
Source
MarketBeat
AD HOC NEWS Direct company coverage

Bruker Corp strengthens its position in advanced scientific instruments as investors watch long-term

Bruker Corp is a global developer of advanced scientific instruments, focusing on high-performance analytical and diagnostic systems for life science and materials research. The company's long-term growth is tied to sustained investment in scientific R&D, with its products critic

Tone
Positive 71/100
Event
Market update
Published
07 Jul 2026 22:48
Source
AD HOC NEWS
Ad-hoc-news.de Direct company coverage

Bruker Corp highlights advanced scientific instruments as investors watch the stock

Bruker Corp (BRKR) is a global provider of advanced scientific instruments and analytical solutions, with its stock performance linked to demand from academic, industrial, and healthcare research. The company's growth is driven by technological innovation, upgrades to its install

Tone
Positive 73/100
Event
Macro sensitivity
Published
03 Jul 2026 17:40
Source
Ad-hoc-news.de
Insider Monkey Direct company coverage

JPMorgan Maintains an “Overweight rating” on Bruker Corporation (BRKR)

JPMorgan analyst Casey Woodring raised the price target for Bruker Corporation (BRKR) to $65 from $45, maintaining an "Overweight rating" on the stock. This revised outlook follows Bruker's announcement of advancements in its microbiology and infection diagnostics portfolio at AS

Tone
Positive 71/100
Event
Analyst action
Published
27 Jun 2026 11:31
Source
Insider Monkey
Ad-hoc-news.de Direct company coverage

Bruker Corp updates its scientific tools portfolio, shares tracked on NASDAQ

Bruker Corp (BRKR) is a significant player in scientific instruments and life-science tools, with its shares tracked on NASDAQ. The company draws analyst attention for its role in advanced proteomics and biopharma workflows, and its revenue is largely driven by mass spectrometry

Tone
Positive 66/100
Event
Earnings
Published
26 Jun 2026 15:11
Source
Ad-hoc-news.de
Moomoo Direct company coverage

Barclays Maintains Bruker Corp(BRKR.US) With Buy Rating, Raises Target Price to $60

Barclays has reiterated its Buy rating on Bruker Corp (BRKR.US) and increased its price target for the stock to $60. This adjustment reflects the firm's continued confidence in Bruker Corp's performance and future outlook.

Tone
Positive 74/100
Event
Analyst action
Published
25 Jun 2026 00:40
Source
Moomoo
Moomoo Direct company coverage

Bruker Is Maintained at Overweight by Barclays

Barclays has maintained its Overweight rating on Bruker (NASDAQ: BRKR) stock. This indicates the firm's continued positive outlook on the company's performance. The article confirms Barclays' stance on Bruker.

Tone
Positive 69/100
Event
Guidance
Published
24 Jun 2026 19:09
Source
Moomoo
TradingKey Direct company coverage

Bruker Corp (BRKR) Institutional Confidence

Bruker Corp (BRKR) has an institutional shareholding score of 10.00, placing it first in the Healthcare Equipment & Supplies industry. This score reflects a 91.74% institutional shareholding proportion, which saw a 2.53% quarter-over-quarter decrease. Steven Cohen is the largest

Tone
Positive 62/100
Event
Market update
Published
24 Jun 2026 07:10
Source
TradingKey
TradingKey Direct company coverage

Bruker Corp (BRKR) Technical Analysis: Support, Resistance, Indicators & Moving Averages

This article provides a technical analysis of Bruker Corp (BRKR), including its price momentum, support and resistance levels, and various technical indicators and moving averages. The current price momentum score is 7.38, suggesting suitability for range-bound swing trading betw

Tone
Neutral 50/100
Event
Market update
Published
22 Jun 2026 18:39
Source
TradingKey
TradingKey Direct company coverage

Bruker Corp (BRKR) Earnings Forecast: Future EPS & Revenue Growth Estimates

This article provides an earnings forecast for Bruker Corp (BRKR), including its current earnings forecast score, average analyst price target, and a breakdown of analyst ratings. It also addresses frequently asked questions about expected revenue, price targets, and past EPS per

Tone
Positive 70/100
Event
Earnings
Published
20 Jun 2026 03:40
Source
TradingKey
TradingKey Direct company coverage

Bruker Corp (BRKR) Revenue Breakdown: Business Segments, Regional Revenue & Profit Contribution

This article provides a detailed revenue breakdown for Bruker Corp (BRKR), categorizing its income by business segments and geographical regions. It reveals that the "Product" segment accounts for the majority of revenue at 80.50%, with "Service and other revenue" making up the r

Tone
Neutral 50/100
Event
Earnings
Published
17 Jun 2026 07:39
Source
TradingKey
Stock Titan Direct company coverage

Bruker (BRKR) EVP exercises options, sells 2,000 pre-planned shares

Bruker Corp's EVP Mark Munch exercised stock options to acquire 2,000 shares at $22.19 per share and simultaneously sold all 2,000 shares in an open-market transaction at $54.76 per share. This transaction was pre-planned under a Rule 10b5-1 trading plan. Following these actions,

Tone
Neutral 50/100
Event
Market update
Published
16 Jun 2026 20:10
Source
Stock Titan